This week it is unavoidable not to mention omicron and so we’ve decided to dedicate our issue of “5 things in life sciences” to this very topic. In a twist from all of the articles about “what we know” about the new variant, however, we thought the community would be better served to talk about what we ... READ MORE >
5 things to know in life sciences: Week of November 15
This week we look at the Food and Drug Administration’s approval of a virtual reality system to treat chronic lower back pain. We also explore a new round of anti-amyloid drugs seeking FDA approval to treat Alzheimer’s disease, a sustainable method to manufacture pharmaceuticals, another deal to license ... READ MORE >
5 things to know in life sciences: Week of November 1
The life sciences industry saw the first meaningful activity around drug pricing reform as Democratic lawmakers included language in their domestic spending package. At the same time, innovation and investment continue to exemplify the life sciences ecosystem. By the way, we’re a little late in getting ... READ MORE >
5 things to know in life sciences: Week of October 25
This week we explore a nanotube sensor capable of detecting COVID-19 in five minutes. We also look at a new method that has the potential to improve gene editing systems, a new blood screening test for detecting early stages of cancer, an artificial intelligence startup focused on improving new drug ... READ MORE >
5 things to know in life sciences: Week of Oct. 18
For the first time, researchers at New York University have successfully transplanted a genetically engineered kidney from a pig into a human patient. This is a remarkable milestone as animal organs have traditionally been rejected by humans. The development could play a critical role in the treatment of ... READ MORE >
5 things to know in life sciences: Week of October 11
Even in normal times, being the head of a major agency like the U.S. Food and Drug Administration would be challenging. These are far from normal times, so challenges will likely be even greater for the person expected to be nominated by President Biden. This week we also look at preparing for a pandemic ... READ MORE >
5 things to know in life sciences: Week of October 4
For the first time, artificial intelligence developed by DeepMind, one of the world’s premier AI labs, has been used to significantly advance scientific research. The project, known as AlphaFold, uses AI to predict the configuration of a protein. With an estimated 10300 configurations, the task is highly ... READ MORE >
5 things to know in life sciences: Week of September 27
Telehealth has been one of the big developments in health care brought on by the COVID-19 pandemic. It both promises to make care easier for patients to fit into their busy lives and holds the potential of allowing trials and new treatments to reach people far from the research hospitals in city centers. ... READ MORE >
5 things to know in life sciences: Week of September 20
As the delta variant ravages communities throughout the Unites States, it is important to look past the data and remember that every infection, hospitalization and death leaves an indelible mark on that patient’s family and community. And few communities have suffered as much as Black communities in the ... READ MORE >
5 things to know in life sciences: Week of September 13
This week we explore promising developments in CRISPR genome editing, also known as clustered regularly interspaced short palindromic repeats, a bacterial defense system. We also look at two of the latest U.S. Food and Drug Administration’s approvals, including another one for a surgical robot that ... READ MORE >